Ioannis Vogiatzis
Director/Board Member at TRASTOR REAL ESTATE INVESTMENT COMPANY SA
Network origin in Ioannis Vogiatzis first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Real Estate Investment Trusts | 14 | |
Public Company | Marine Shipping | 11 | |
Private Company | Hospital/Nursing Management | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ioannis Vogiatzis via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
DRYSHIPS INC. | Marine Shipping | Corporate Officer/Principal | |
Varde Partners LP
Varde Partners LP Investment ManagersFinance Varde Partners LP engages in the management of funds. It is the managing member of Fund XI GP, Fund XII UGP, Skyway Fund GP, and VIP GP with Varde Partners, Inc. as its General Partner. The company was founded on May 16, 1994 and is headquartered in Minneapolis, MN. | Investment Managers | Corporate Officer/Principal | |
University of Pittsburgh | College/University | Masters Business Admin | |
ELLAKTOR S.A. | Engineering & Construction | Director/Board Member | |
VIRBAC | Biotechnology | Director/Board Member | |
Blue Star Ferries
Blue Star Ferries Marine ShippingTransportation Blue Star Maritime S.A.The Company's principal activities are the provision of passenger and goods transport by sea and related tourist services in the Mediterranean region under the name of Blue Star Ferries. The Company's fleet consists of 12 owned vessels | Marine Shipping | Sales & Marketing | |
MIG HOLDINGS S.A. | Real Estate Development | Director/Board Member Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Suffolk University | College/University | Undergraduate Degree | |
St. John's University | College/University | Undergraduate Degree | |
NBG Finance Plc
NBG Finance Plc Finance/Rental/LeasingFinance NBG Finance Plc, part of National Bank of Greece SA, is a British company located in London that acts as a financing subsidiary/Special purpose entity. | Finance/Rental/Leasing | Chairman | |
University of Bristol | College/University | Graduate Degree | |
London School of Economics & Political Science | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
University of Sussex | College/University | Undergraduate Degree Graduate Degree | |
University College London | College/University | Graduate Degree | |
University of Giessen | College/University | Graduate Degree | |
National & Kapodistrian University of Athens | College/University | Undergraduate Degree Graduate Degree | |
University of Piraeus | College/University | Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
University of Hertfordshire | College/University | Masters Business Admin | |
University of Grenoble | College/University | Graduate Degree | |
NBGI SEE Real Estate Fund LP
NBGI SEE Real Estate Fund LP Investment ManagersFinance NBGI SEE Real Estate Fund LP invests in small to medium-sized real estate or real estate owning companies. It focuses on companies operating in Central & South East Europe, and selectively Western Europe. | Investment Managers | Director/Board Member | |
Specifar SA
Specifar SA Pharmaceuticals: MajorHealth Technology Specifar SA specializes in development, production, distribution, sales and marketing of pharmaceutical products. It offers tablets, capsules, liquids, and semisolids for various therapeutic areas, including oncology, hematology, metabolic disease, immunology, anemia, diabetes and central nervous system. The firm also provides pharmaceutical dossiers licensing and intellectual property services. The company was founded in 1933 and is headquartered in Athens, Greece. | Pharmaceuticals: Major | Chief Executive Officer | |
ELPEN Pharmaceutical Co., Inc.
ELPEN Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology ELPEN Pharmaceutical Co., Inc. researches, develops, manufactures, and markets branded generic and original pharmaceutical products. The firm has also developed ELPENHALER, a proprietary dry powder inhaler device, developed for the uptake of powdered medication via inhalation. The company was founded by Dimitrios Pentafragas in 1969 and is headquartered in Pikermi, Greece. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Piraeus Real Estate SA
Piraeus Real Estate SA Real Estate DevelopmentFinance Piraeus Real Estate SA engages in the provision of integrated services of real estate development, utilization and management. Its business activities include: real estate development; project management of construction projects; project management and construction of branch network; consultancy services for real estate utilization and management; property and facilities management; consultancy services for real estate investments; appraisals-mediations and technical consultancy services for public private partnership. The company was founded in 1999 and is headquartered in Athens, Greece. | Real Estate Development | Chief Executive Officer | |
Picar Single Member SA | Chief Executive Officer | ||
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member | |
Economic Chamber of Greece | Director/Board Member | ||
PBTC International Bank | Director of Finance/CFO | ||
Greek Shipowners Association For Passenger Ships | Director-Back Office Operation | ||
Hellenic Financial Stability Fund
Hellenic Financial Stability Fund Financial ConglomeratesFinance Hellenic Financial Stability Fund is a Greek government-controlled financial institution founded in 2010 with the mission to maintain the stability of the Greek banking system. The fund operates on a structured and clear roles framework, with a general council consisting of seven non-executive members and an executive committee of three members. The HFSF investment relations program aims to provide transparent and coherent information to the investment community, organizations, and media in an appropriate, timely, and fair manner. Ultimately, the Hellenic Financial Stability Fund is controlled by the Government of Greece. | Financial Conglomerates | Director/Board Member | |
Panteion University | College/University | Graduate Degree | |
Harvard Business School | College/University | Masters Business Admin | |
Harvard Law School | College/University | Graduate Degree | |
Rotterdam School of Management | College/University | Masters Business Admin | |
Magna Marine, Inc.
Magna Marine, Inc. Marine ShippingTransportation Magna Marine, Inc. provides deep sea freight transportation services. | Marine Shipping | Chief Executive Officer | |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
BIOVENTUS INC. | Medical Specialties | Director/Board Member | |
International Hellenic University | College/University | Undergraduate Degree | |
POLAREAN IMAGING PLC | Medical Specialties | Director/Board Member | |
Hellenic Bankers Association Uk | Chairman | ||
Blue Earth Diagnostics, Inc. | Director/Board Member | ||
Cyrille Petit Conseil SAS | Chairman | ||
Université Paris-Saclay | College/University | Graduate Degree | |
Nexia Poyiadjis | Corporate Officer/Principal | ||
Bracco Horizons Ltd.
Bracco Horizons Ltd. BiotechnologyHealth Technology Founded in 2019, Bracco Horizons Ltd. is a British biotechnology company that engages in research and development of biotechnology products. Part of Bracco SpA, the private company is based in Oxford, UK. | Biotechnology | Director/Board Member | |
Innovis Pharma SA
Innovis Pharma SA Pharmaceuticals: MajorHealth Technology Innovis Pharma SA is a Greek healthcare company that offers a range of products to meet the diverse healthcare needs of individuals. The private company is based in Marousi, Greece. With a commitment to quality and safety, Innovis Pharma strives to improve health outcomes and enhance the quality of life for its customers. The company is a trusted healthcare partner dedicated to improving lives. Innovis Pharma was founded in 2007, and Thomas Georgios Oikonomou has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer | |
Ila Pothecary Ltd. | Director/Board Member | ||
Athens University of Economics & Business | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree |
Statistics
International
Greece | 20 |
United Kingdom | 14 |
United States | 11 |
France | 4 |
Germany | 2 |
Sectoral
Consumer Services | 20 |
Finance | 9 |
Health Technology | 8 |
Transportation | 5 |
Industrial Services | 2 |
Operational
Director/Board Member | 47 |
Corporate Officer/Principal | 24 |
Graduate Degree | 23 |
Undergraduate Degree | 15 |
Independent Dir/Board Member | 13 |
Most connected contacts
- Stock Market
- Insiders
- Ioannis Vogiatzis
- Company connections